TBX3 and Glucose intolerance: Surprisingly, Tbx3-KO mice exhibited increased glucose intolerance, fasting hyperinsulinemia, and increased plasma triglycerides and non-esterified fatty acids (Figure 4, A–D), all of which indicated increased insulin resistance.